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Introduction
Childhood obesity is increasing in prevalence, and longitudinal studies have shown that elevated BMI tracks 
strongly from childhood into adulthood, increasing the future risk of  chronic disease such as type 2 diabetes 
mellitus (T2DM), cardiovascular disease, and certain cancers (1). Twenty percent of  adult cancer cases are 
attributed to being overweight or obese (2). In obese adult populations, increased incidences of  multiple can-
cer types are described, including oesophageal, pancreatic, ovarian, renal cell carcinoma, endometrial, and 
certain hematopoietic malignancies (3). In obese children, there are reports of  worse outcomes in hemato-
logical cancers, such as acute lymphoblastic leukemia and acute myeloblastic leukemia (4, 5). Additionally, 
larger body size in childhood and adolescence is associated with increased risk of  non-Hodgkin’s lymphoma 
later in life (6). A recent study that investigated cancer rates in a cohort of  1.79 million Israeli men and 
women over a median of  23 years reported that increased BMI in adolescence was associated with increased 
risk of  colorectal and rectal cancer (7). The mechanisms by which obesity increases cancer risk remain to be 
fully elucidated. However, research indicates that they are multifactorial, with sedentary lifestyle emerging 
as a major contributor (8). Two established factors driving cancer risk are immune system dysregulation and 
chronic low-grade inflammation; both of  which are well described in obesity. Dysregulated inflammation 
leads to altered cytokine and adipokine profiles, which are intrinsically linked to cancer development (9, 
10). Recently, we reported immune system dysregulation and chronic low-grade inflammation in a cohort of  
obese children with a mean age of  13 years (11). NK cells are innate effector cells that are capable of  carrying 
out potent cytotoxic actions against tumor cells without previous exposure (12). In addition to transformed 
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obese. Obesity has been linked to the development of numerous chronic inflammatory diseases, 
including type 2 diabetes and multiple cancers. NK cells are a subset of innate effector cells, which 
play an important role in the regulation of adipose tissue and antitumor immunity. NK cells can 
spontaneously kill transformed cells and coordinate subsequent immune responses through their 
production of cytokines. We investigated the effect of obesity on NK cells in a cohort of obese 
children, compared to children with a healthy weight. We demonstrated a reduction in peripheral 
NK cell frequencies in childhood obesity and inverse correlations with body mass index and insulin 
resistance. Compared with NK cells from children with normal weight, we show increased NK cell 
activation and metabolism in obese children (PD-1, mTOR activation, ECAR, and mitochondrial 
ROS), along with a reduced capacity to respond to stimulus, ultimately leading to loss of function 
(proliferation and tumor lysis). Collectively we show that NK cells from obese children are activated, 
metabolically stressed, and losing the ability to perform their basic duties. Paired with the reduction 
in NK cell frequencies in childhood obesity, this suggests that the negative effect on antitumor 
immunity is present early in the life course of obesity and certainly many years before the 
development of overt malignancies.
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tumor cells, NK cells can respond to allogeneic, virus-infected, and stressed cells (13, 14). NK cells are early 
potent producers of  IFN-γ, a cytokine that plays a key role in tumor immunosurveillance and activates the 
inflammatory cascade against neoplastic threat (15). In patients and animal models with impaired or depleted 
NK cells, there is a strong association with recurring viral infections and incidence of  certain cancers (16, 17). 
NK cells are defined by their expression of  the surface molecule CD56 and the lack of  the T cell marker CD3. 
NK cells can be further separated in CD56bright and CD56dim subsets. CD56 bright NK cells are considered to 
be less cytotoxic than their dim counterparts but do show increased cytokine production. Given that NK cell 
numbers are decreased and display functional impairment in obese adults, we hypothesized that these deficits 
may also be present in a cohort of  obese children (18–20). Furthermore, analysis of  pediatric patients allows 
examination of  immune function prior to onset of  metabolic complications such as T2DM and thus may 
provide a good model for identification of  mechanisms of  obesity-related impaired immune function. Finally, 
it has recently been demonstrated that NK cell functions are affected by intrinsic cell metabolism (21, 22). 
Therefore, we hypothesized that the altered environment in childhood obesity might affect NK cell metabo-
lism and drive dysfunction.
Results
We initially investigated the frequencies of  NK cells in a cohort of  obese and lean children aged 6–17 years 
of  age (clinical cohort described in Table 1). NK cell frequencies and absolute numbers were reduced in obese 
children (Figure 1, A–C). NK cell frequencies negatively correlated with BMI Z score (Figure 1, D and E). 
Homeostatic model of  assessment for insulin resistance (HOMA-IR) calculations demonstrated significantly 
higher levels of  insulin resistance in our obese cohort, which coincided with a significant decrease in NK 
cell frequencies in children with a HOMA-IR of greater than 3.1, indicative of  an insulin-resistant state (23) 
(Figure 1, F and G). No associations were observed between NK cell frequencies and total cholesterol (Sup-
plemental Figure 1E; supplemental material available online with this article; https://doi.org/10.1172/jci.
insight.94939DS1). Additionally, pubertal status did not affect the frequencies of  NK cells (data not shown). 
Obese children displayed an increase in CD56bright (cytokine-producing) NK cells, with a corresponding reduc-
tion in the frequency of  CD56dim (cytotoxic) NK cells (Supplemental Figure 1, B–D).
In addition to NK cell frequencies, we investigated a panel of  NK cell–activating and –inhibitory mole-
cules. Of  the molecules investigated, only CD69 and program death-1 (PD-1) displayed differences (Figure 
2 and Supplemental Figure 2). NK cells from obese children expressed higher basal levels of  the activation 
marker CD69 (Figure 2A). Obese children also expressed higher levels of  the exhaustion marker PD-1 
following cytokine stimulation on their NK cells (Figure 2, B–D). To investigate if  obesity in the absence 
of  comorbidities and/or polypharmacy affected NK cell effector functions, we isolated NK cells from both 
lean and obese children and challenged their functional abilities in vitro following stimulation with two 
key cytokines (IL-15 and IL2) necessary for cellular proliferation and survival. NK cells isolated from lean 
children displayed consistent proliferation responses to these cytokines, with a significant increase in cell 
number on day 7 (Figure 2, E and G). In contrast, NK cells isolated from obese children did not proliferate 
consistently and failed to significantly expand after 7 days (Figure 2, F and G).
The primary effector function of  NK cells is their ability to lyse transformed or virally infected cells. 
We investigated this function by coculturing NK cells with a NK cell–sensitive tumor cell line, K562, 
Table 1. Cohort characteristics
Lean Obese P value
n 45 45 –
Age (yr [range]) 12.42 (6.5–16.52) 13.12 (6.14–16.83) 0.58
Sex (% male) 55.6% 57.7% –
BMI Z score 0.06 (–2.3–1.5) 2.82 (1.07–4.5) <0.0001
Weight (kg) 42.1 (18.9–82) 87.89 (30–154) <0.0001
Height (cm) 147.5 (111–196) 160.5 (124–182) <0.01
HOMA-IR 0.74 (0.28–4.4) 3.29 (0.33–16.1) <0.0001
Fasting glucose (mmol/l) 5.02 (3.5–5.6) 5.03 (3.4–6.6) 0.93
Fasting insulin (mmol/l) 25.2 (13–81) 139 (11–900) <0.0001
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for 4 hours. NK cell numbers were normalized to account for the reduction in cell numbers in obese 
children. NK cells isolated from obese children killed significantly fewer K562 tumor cells compared 
with their lean counterparts (Figure 2H). We also investigated lytic molecule expression by NK cells 
after coculture with K562 and showed that NK cells from obese children express reduced levels of  both 
granzyme B and perforin when compared with lean controls (Figure 2, I–L).
NK cells can also exert their effector function via the production of  cytokines, in particular IFN-γ. 
Therefore, we next examined the capacity of  both lean and obese NK cells to produce IFN-γ following 
cytokine stimulation. When challenged, NK cells isolated from both lean and obese children readily 
produced IFN-γ (Figure 2, M and N).
Recent studies have shown that NK cell effector function is intrinsically linked to cell metabolism (21, 
22). NK cells rely on metabolic reprogramming for effector function. Inhibition of  either glycolysis or the 
glycolytic regulator mammalian target of  rapamycin complex 1 (mTORC1) results in diminished effector 
responses by NK cells, such as cytokine production (21, 22). Therefore, we investigated the effect of  obe-
sity on pediatric NK cell metabolic reprogramming. Initially, we examined the expression of  a major glu-
cose transport, Glut-1, on NK cells and found no difference between lean and obese cohorts (Figure 3A). 
We next assessed the ability of  NK cells to take up a fluorescent glucose analog, 2-NBDG. We observed 
increased 2-NBDG uptake by NK cells isolated from lean children upon activation but noted that NK cells 
from obese children had a trend toward increased basal glucose consumption (Figure 3, B and C).
As NK cells use mTOR for nutrient sensing and metabolic reprogramming, we next studied the acti-
vation of  mTORC1 via the phosphorylation of  ribosomal S6 protein (pS6). NK cells from obese children 
displayed higher levels of  mTORC1 activation both basally and after 4 hours of  cytokine stimulation, 
when compared with NK cells from lean children. Following 18 hours of  stimulation, obese NK cell 
Figure 1. NK cell frequencies are reduced in childhood 
obesity. (A) Representative dot plots showing NK cells from 
a lean and an obese child. (B) Scatter plot showing NK cell 
frequencies (as a percentage of total lymphocytes) in lean (n 
= 35) and obese (n = 35) childhood cohorts. (C) Scatter plot 
displaying absolute number of NK cells (CD56+ cells/μl of 
blood) in a cohort of lean and obese children (n = 10/cohort). 
(D) Scatter plot detailing the BMI Z score of the lean and 
obese cohorts, and (E) correlation plot showing the negative 
association between NK cell frequencies and BMI Z score 
(Pearson R = –0.465, P = 0.0002). (F) Scatter plot detailing 
the HOMA-IR score of the lean and obese childhood cohorts. 
(G) Scatter plots detailing the frequencies of NK cells in 
obese children separated according to HOMA-IR insulin-sen-
sitive (<3.1) and insulin-resistant (>3.1) groups. Statistical 
comparisons using Student’s t test. **P ≤ 0.01, ***P < 
0.001, ****P < 0.0001.
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Figure 2. NK cells from obese children display increased activation and diminished effector responses. (A) Bar graph and representative dot detailing 
the percentage of NK cells expressing CD69 in lean and obese childhood cohorts (n = 5). Bar graphs showing (B) basal or (C) IL-2/IL-12–stimulated PD-1 
expression (MFI) on NK cells from lean and obese children. (D) Representative dot plot showing PD-1 expression on stimulated NK cells from a lean and an 
obese donor. The numbers represent the MFI for the histograms on which they are displayed, the black corresponds to leans as per the histogram and grey 
represents obese MFI (D, J, and L). Plots showing the expansion of NK cells from (E) lean and (F) obese children following 7 days of IL-2/IL-15 stimulation. 
(G) Scatter plot showing the fold expansion (over baseline numbers) of NK cells from lean and obese children stimulated with IL-2/IL-15 for 7 days. (H) Bar 
graph showing the number of K562 tumor cells lysed (10:1 effector/target ratio) in 4 hours by NK cells isolated from either lean or obese children. (I and 
J) Bar graph and representative histogram showing granzyme B levels on K562 cells cocultured with NK cells from lean or obese children. (K and L) Bar 
graph and representative histogram showing perforin levels on K562 stimulated NK cells from lean or obese children. (M) Bar graph showing IL-2/IL-12–
stimulated NK cell production of IFN-γ in a cohort of lean and obese children. (N) Representative dot plot showing IFN-γ production by NK cells basally or 
stimulated with IL-2/IL-12 for 18 hours. Data are representative of a minimum of 10 independent experiments. Statistical comparisons using Student’s t 
test. *P < 0.05, **P ≤ 0.01.
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mTORC1 activity did not significantly increase over basal 
levels (Figure 3, D and E, and Supplemental Figure 3). We 
next utilized Seahorse XF technology to investigate NK cell 
glycolysis rates in a subset of  lean and obese children. Sim-
ilar to the mTORC1 profile, NK cells isolated from obese 
children displayed elevated basal extracellular acidification 
rates (ECARs; a surrogate measure of  glycolysis) levels 
compared with NK cells from lean children (Figure 3F).
Previous studies have shown that, upon activation, murine NK cells display increased mitochondrial 
stress in the form of increased ROS, followed by contraction in mitochondrial mass, due to increased mito-
phagy (24). We investigated if  the apparent chronic metabolic activation of  NK cells isolated from obese 
children affected mitochondrial frequencies or stress. We found that NK cells isolated from obese children 
showed no difference in mitochondrial mass compared with lean children, as measured by MitoTracker (Fig-
ure 3G), but did show increased mitochondrial ROS, measured by MitoSOX (Figure 3, H and I).
Discussion
In this study, we show that in obese children NK cells are reduced in frequency, display an activated metabolic 
phenotype, and are losing their ability to exert their effector functions, such as cytotoxicity. NK cells are a critical 
component of the immune system. Their primary functions are in antitumor and antiviral defenses. NK cells 
have an innate ability to recognize infected or transformed cells and subsequently kill the target cell, while initi-
ating an adaptive immune response if  required. We show that NK cells are reduced in the peripheral blood of  
obese children when compared with a cohort of lean counterparts. Previously, we reported a reduction in NK 
cell frequencies in a cohort of severely obese adults. In the same study, we showed that NK cell defects were 
more pronounced in metabolically unhealthy obese adults than metabolically healthy obese adults (25). This 
fits with the findings of the current study that the reduction in NK cell frequencies correlated negatively with 
BMI Z score and insulin resistance. We show that childhood obesity negatively affects cytokine-driven NK cell 
proliferation and suggest that this may explain the reduced frequencies of NK cells observed in our obese cohort.
NK cells from obese children expressed higher levels of the activation marker CD69 and, upon stimu-
lation, significantly upregulated PD-1, indicating that these cells are highly activated and become exhausted 
much quicker when challenged, compared with their lean counterparts. Guo and colleagues reported that NK 
cells expanded in the presence of a blocking antibody against PD-1, demonstrating increased cytolytic activ-
Figure 3. NK cells from obese children display increased mTORC1 
activity, ECAR, and mitochondrial ROS. (A) Bar graph detailing 
the expression (MFI) of Glut-1 by NK cells from lean and obese 
children (n = 10 obese). (B and C) Representative histogram 
and bar graphs showing basal or stimulated 2-NBDG uptake by 
NK cells isolated from lean and obese children. The numbers 
represent the MFI for the histograms on which they are displayed, 
the black corresponds to leans as per the histogram and grey 
represents obese MFI. (D) Representative histograms and (E) bar 
graphs detailing MFI of phosphorylation of ribosomal S6 protein 
(pS6) expression (mTORC1 activity) in NK cells from lean or obese 
children. Expression of pS6 was measured in resting NK cells 
(basal) and cytokine-stimulated NK cells after 4 hours or 18 hours 
(n = 5). (F) Bar graph showing the extracellular acidification rate 
(ECAR) of basal or stimulated NK cells from lean or obese children 
(n = 4). (G) Bar graph showing the mitochondrial mass (MitoTrack-
er Green) of NK cells from lean and obese children. (H) Represen-
tative histogram showing mitochondrial ROS (MitoSOX) MFI in 
NK cells from a lean and an obese child (n = 9 obese). The num-
bers represent MFI for the histograms. The black font represents 
lean NK cell mitosox MFI value and grey is the obese. (I) Bar graph 
showing mitochondrial ROS levels (MFI) in NK cells from lean 
and obese children. Data are representative of a minimum of 10 
independent experiments, unless otherwise noted. Statistical 
comparisons using Student’s t test or ANOVA with multiple com-
parisons for groups of 3 or more data sets. *P < 0.05.
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ity against myeloma cells (26). We also examined the NK cell–related molecules NKG2D, TIM-3, CD158a, 
CD158b, CD16, CD25, and CD95 and identified no difference between lean and obese children. A recent study 
by Theurich and colleagues reported no difference between lean and obese NK cells in their expression of many 
classical NK cell molecules, such as the NKG2 family (20).
Previous studies in obese adults with T2DM reported a loss of  NK cell tumor lysis capabilities (18). Our 
childhood cohort allows us to investigate the effect of  obesity on the immune system, outside of  comorbidi-
ties and polypharmacy. We show that NK cells isolated from obese children display dysregulated expansion 
capabilities; a subset of  our obese cohort displayed normal expansion, while NK cells of  several patients in 
the cohort displayed a complete failure to expand. We show that NK cells isolated from obese children dis-
play reduced tumor lysis capabilities and lytic molecule production. A prospective study has demonstrated 
a relationship between the natural cytotoxicity of  peripheral blood mononuclear cells (PBMCs) and cancer 
risk, identifying those with the lowest cytotoxic activity as having the highest cancer risk. This finding suggests 
that the loss of  NK cell cytotoxicity in obesity may contribute to the future risk of  developing disease (16). 
Due to the small sample volume available from children, we did not investigate antibody-dependent cellular 
cytotoxicity, which remains to be elucidated in childhood obesity. Encouragingly, a study investigating NK 
cell cytotoxic function before and after bariatric surgery found that defective NK cell cytotoxicity observed in 
a cohort of  severely obese adults improved after surgery (27). This suggests the defects in NK cell cytotoxic 
function that are driven by obesity are reversible.
Upon activation, NK cells undergo metabolic reprogramming, increasing rates of both oxidative phosphor-
ylation and aerobic glycolysis (28). This reprogramming ensures that NK cells have the energy and biological 
intermediates required to produce effector molecules, such as lytic granules and cytokines. We demonstrated 
that NK cells isolated from obese children have altered cellular metabolism when compared with lean counter-
parts. We observed increased 2-NBDG uptake by NK cells isolated from lean children upon activation but did 
not see this in NK cells from obese children. However, we noted that NK cells from obese children had a trend 
toward increased basal 2-NBDG uptake, in agreement with the concept of an activated population. NK cells 
utilize mTOR for metabolic reprogramming. We discovered that the activation of mTORC1 was higher in NK 
cells from obese children both basally and after 4 hours of stimulation, supporting our findings of an activated 
phenotype. Following 18 hours of stimulation, obese NK cell mTORC1 activity did not significantly increase, 
unlike that in lean counterparts, suggesting that NK cells from obese children are maximally activated in the bas-
al state. Similar to these findings, in a model of LCMV infection, the Wherry group reported elevated mTORC1 
activity in T cells from mice with chronic LCMV infection and a subsequent reduction in responsiveness to 
stimulation (29). To confirm the concept of a metabolically activated NK cell, we performed Seahorse analysis 
on a subset of our cohort. We showed that basal ECARs, a surrogate for glycolysis, are elevated in NK cells from 
obese children and were not increased upon stimulation, consistent with our mTORC1 findings.
Keating and colleagues have recently shown that NK cell function is also highly dependent on mito-
chondrial OxPhos (28). We demonstrated large increases in mitochondrial ROS in NK cells from obese 
children, indicating mitochondrial stress, suggesting that possible dysfunction may contribute to alterations 
in these cells. Data from the Sun lab has shown that upon activation murine NK cells display increased 
mitochondrial stress in the form of  increased ROS (24). These data also show that survival of  these murine 
NK cells relied upon mitophagy-mediated clearance of  these dysfunctional mitochondria (24). Therefore, 
the observed mitochondrial dysfunction in NK cells from obese children may contribute to the observed 
decreased NK cell numbers and impaired effector function. Indeed, several studies in T lymphocytes, in the 
context of  chronic viral infection, support the argument that mitochondrial dysfunction is linked to lympho-
cyte dysregulation (29–31). Fisicaro and colleagues demonstrated that chronic hepatitis B infection resulted 
in exhausted dysfunctional CD8 T cells, which expressed PD-1 and displayed mitochondrial defects, includ-
ing elevated mitochondrial ROS, drawing striking similarities to the effect of  obesity on NK cells (30).
Overall, our data show that obese children have a reduced population of  circulating NK cells that 
are highly activated, metabolically stressed, and underperforming in their basic duties. These observations 
prove that the negative effect of  obesity on antitumor immunity is present in children.
Methods
Study cohorts. A cohort of  90 children (45 obese/45 nonobese) aged between 6 and 17 years were recruited 
(Table 1). Experiments detailed in Figures 2 and 3 were performed on a subset of  these cohorts (numbers 
as denoted in figure legends). Clinical assessments (height, weight, fasting insulin, fasting glucose, lipid 
7insight.jci.org   https://doi.org/10.1172/jci.insight.94939
R E S E A R C H  A R T I C L E
profiles) were performed as part of  the participants’ routine care. Biochemical measurements (insulin, glu-
cose, lipids, and absolute cell numbers) were measured by the clinical Biochemistry and Haematology labs 
at Our Lady’s Children’s Hospital Crumlin. Inclusion and exclusion criteria and the clinical investigation 
protocol are as previously described (11).
Preparation of  PBMCs and flow cytometric analysis. PBMC samples were isolated by density centrifu-
gation. NK cell staining (1 × 106 PBMCs) was performed using specific surface monoclonal antibodies, 
namely CD56 PerCp-Vio700 (Miltenyi Biotec, clone REA196) and CD3 VioGreen (Miltenyi Biotec, clone 
REA613), and represented as percentages of  total lymphocytes (unless otherwise stated). NK cells were 
defined as CD56+, CD3– lymphocytes. Other markers of  NK cell activation and exhaustion examined were 
CD69 APC-Vio770 (Miltenyi Biotec, clone FN50), PD-1 PE-Vio770 (Miltenyi Biotec, clone PD1.3.1.3), 
CD25 APC (BD Biosciences, clone M-A251), CD16 PE-Vio770 (Miltenyi Biotec, clone REA423), NKG2D 
APC (BD Biosciences, clone 1D11), CD158a PE (BD Biosciences, clone HP-3E4), and CD158b FITC (BD 
Biosciences, clone CH-L). Cell populations were acquired using a BD FACSCanto II and analyzed using 
FlowJo software (Treestar). Results are expressed as a percentage of  the parent population as indicated and 
determined using flow minus-1 (FMO) and unstained controls.
NK cell proliferation analysis. NK cells were isolated from donor PBMC populations using a positive 
selection MACS Magnetic Bead (Miltenyi Biotec) isolation technique, as per the manufacturer’s instruc-
tions. NK cells were cultured (1 × 106 cells/ml) in the presence of  IL-15 (5 ng/ml) and IL-2 (20 ng/ml) for 
7 days. NK cell numbers were determined using the Invitrogen Countess system.
NK cell cytotoxicity analysis. PBMCs (for granzyme B and perforin) or isolated NK cells (for tumor lysis) 
were cultured with K562 cell line (ATCC), a myelogenous leukemia cell line, at a ratio of  10:1, respectively, 
for 4 hours at 37°C. Granzyme B (APC, Miltenyi Biotec, clone REA226) and perforin (VioBlue, Miltenyi 
Biotec, clone δ G9) expression was determined by flow cytometry. NK cell cytotoxicity was determined 
using the CytoTox-Fluor cytotoxicity assay (Promega), as per the manufacturer’s instructions.
NK cell cytokine production analysis. Isolated NK cells (1 × 106 cells/ml) were stimulated with IL-15 (5 
ng/ml), IL-2 (20 ng/ml), and IL-12 (30 ng/ml) for 18 hours at 37°C. Culture supernatants were investigat-
ed for IFN-γ secretion by ELISA (Biolegend), as per the manufacturer’s instructions.
NK cell glucose consumption analysis. PBMCs or isolated NK cells (1 × 106 cells/ml) were activated as 
previously described for 18 hours. Cells were washed and transferred to glucose-restricted media in the 
presence of  the fluorescent glucose analog 2-NBDG (Life Technologies) for 2 hours. Additionally, Glut-1 
expression was examined on activated PBMCs or isolated NK cells using specific fluorescently labeled 
mAb (R&D Systems). Glucose uptake and Glut-1 expression were determined using flow cytometry. FMO 
and unstimulated NK cells were used as negative controls.
NK cell mTORC1 and mitochondrial analysis. PBMCs (1 × 106 cells/ml) were activated as previously described 
for 4 or 18 hours. mTORC1 activity in NK cells (CD56+, CD3–) was examined via pS6 (Cell Signalling) by 
flow cytometry. Additionally, NK cell mitochondrial mass (MitoTracker) and stress (MitoSOX) were examined. 
Briefly, prior to NK cell surface staining on PBMCs, cells were stained with MitoTracker Green FM (200 nM) 
or MitoSOX Red (5 μM) for 30 minutes at 37°C, as per the manufacturer’s instructions. Fully stained cells were 
analyzed by flow cytometry. FMO and unstimulated NK cells were used as negative controls.
NK cell Seahorse analysis. Isolated NK cells were activated as previously described for 18 hours. After 
cell stimulation, the ECAR was measured in 250,000 purified NK cells per well using a Glycolysis Stress 
Test Kit and an XFp Extracellular Flux Analyzer, according to the manufacturer’s instructions (Seahorse 
XF96 Technology, Agilent). Each cell culture condition was evaluated in quadruplicate, and 12 measures 
were made per sample. The ECAR linked with basal glycolysis pathway activation was measured after the 
addition of  glucose (10 mM) in cell culture.
Statistics. Statistical analysis was completed using GraphPad Prism 6 software. Data are expressed as 
SEM. We determined differences between two groups using 2-tailed Student’s t test and Mann-Whitney 
U test where appropriate. Differences between three or more groups were determined using ANOVA with 
multiple comparisons. Correlations were determined using linear regression models and expressed using 
Pearson or Spearman’s rank correlation coefficient as appropriate. P values were expressed with signifi-
cance set at < 0.05.
Study approval. Ethical approval was granted by the Medical Research Ethics Committees at Our Lady’s 
Children’s Hospital Crumlin. The parents of  all pediatric patients gave written informed consent prior to 
patient participation in the study.
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